AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimwin-M2 Tablet ER

Prescription Icon
Prescription Required

Marketer

Healthkind Labs Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimwin-M2 Tablet ER

Diabexe Duo ER tablets are a dual-action antidiabetic medication, combining two active ingredients to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabexe Duo ER should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your healthcare provider. Lifestyle modifications are vital for diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms – sweating, dizziness, headache, tremors – and appropriate countermeasures. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Uses of Glimwin-M2 Tablet ER

Managing type 2 diabetes

Major Benefits of Glimwin-M2 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glimwin-M2 Tablet ER with a meal.

Common Side effects of Glimwin-M2 Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimwin-M2 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimwin-M2 Extended-Release tablets should be administered with a meal.

How Glimwin-M2 Tablet ER works:

Glimwin-M2 Extended-Release tablets contain a dual-action antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimwin-M2 Tablet ER is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimwin-M2 Tablet ER during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimwin-M2 tablets are contraindicated for breastfeeding mothers due to the potential for infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Glimwin-M2 Tablet ER cautiously, potentially requiring a modified dosage. Physician consultation is necessary. The medication is contraindicated in individuals with severely compromised renal function. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimwin-M2 Tablet ER to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. For patients exhibiting mild to moderate liver dysfunction, initiate Glimwin-M2 Tablet ER therapy at a reduced dosage; avoid use in those with severe liver disease.

What if you forget to take Glimwin-M2 Tablet ER :

Should you forget a dose of Glimwin-M2 Extended-Release Tablet, take it immediately if you remember. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimwin-M2 Tablet ER

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimwin-M2 Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimwin-M2 Tablet ER can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimwin-M2 Tablet ER and seek immediate medical attention.
Glimwin-M2 ER tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Glimwin-M2 Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glimwin-M2 Tablet ER use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 at least annually is recommended by some researchers.
Glimwin-M2 Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimwin-M2 Tablet ER and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimwin-M2 Tablet ER
39
MRP 47
17% off